Corcept Therapeutics | Betriebsaufwand



Operating Expenses Veränderung Datum
Acadia Pharmaceuticals USD 232.19M 7.16M 2025-06
Alaunos Therapeutics USD 759K 391K 2024-12
ANI Pharmaceuticals USD 196.2M 25.27M 2025-06
Ardelyx USD 108M 12M 2024-12
Aurora Cannabis CAD 51.98M 31.53M 2024-12
BioMarin Pharmaceutical USD 548.52M 27.27M 2025-06
Bristol-Myers Squibb USD 8.5B 265M 2025-06
Canopy Growth CAD 98.58M 10.03M 2024-12
Corcept Therapeutics USD 167.76M 13.96M 2025-06
Eli Lilly USD 8.54B 1.22B 2025-06
J&J USD 16.8B 8.54B 2025-06
Knight Therapeutics CAD 89.06M 2.02M 2024-09
Merck USD 9.44B 217M 2025-06
Novartis USD 9.97B 1.02B 2025-06
Novartis USD 10.15B 579M 2024-12
Pacira USD 170.87M 3.93M 2025-06
Pfizer USD 11.62B 1.58B 2025-06
Supernus Pharmaceuticals USD 153.31M 892K 2025-06
TG Therapeutics USD 106.3M 5.93M 2025-06


Corcept Therapeutics Betriebsaufwand - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Aug 2025.